Boc-D-His(1-Me)-OH

Boc-D-His(1-Me)-OH is a Boc-protected D-configured histidine derivative bearing an N-methyl substitution on the imidazole-bearing side chain, which modulates side-chain protonation behavior and steric environment. As a protected amino acid building block, it is commonly used in peptide synthesis workflows where controlled amide formation and side-chain handling are required, while the D-stereochemistry enables stereodefined incorporation into peptides and peptidomimetic structures.

1. D-Amino Acid Peptide Building Block

Boc-D-His(1-Me)-OH is used by peptide synthesis groups to introduce a stereodefined D-histidine residue into protected peptide segments, including short peptides, cyclic precursors, and stereochemically constrained analogs. The Boc group provides an N-protected handle for coupling under standard peptide assembly conditions, while the D configuration supports the generation of peptides with defined backbone stereochemistry for structure-activity relationship studies and protease stability evaluations in chemical biology research. The N-methylated imidazole side chain helps maintain a distinct side-chain microenvironment compared with unsubstituted histidine, which is valuable when tuning local charge distribution and hydrogen-bonding patterns in peptide design.

2. Peptidomimetic SAR Intermediates

Boc-D-His(1-Me)-OH is frequently selected by medicinal chemistry and peptidomimetic development teams as a chiral amino acid intermediate for building analog libraries that probe how histidine-like functionality contributes to binding-site interactions. The N-methyl substitution on the imidazole can influence the conformational preferences and protonation state of the side chain, making this building block useful for systematic SAR campaigns where subtle changes in side-chain electronics and sterics are correlated with activity readouts. In practice, the Boc-protected form supports reliable downstream coupling to form amide linkages during the preparation of candidate peptide-like scaffolds and backbone-modified intermediates.

3. Solid-Phase Peptide Synthesis Segments

Boc-D-His(1-Me)-OH is commonly incorporated into solid-phase peptide synthesis (SPPS) workflows by researchers who require a protected, stereodefined amino acid unit for stepwise chain elongation. The Boc-protected amino terminus enables controlled coupling chemistry during segment assembly, supporting the preparation of longer sequences where consistent protection strategy helps minimize side reactions. Because the product is a D-amino acid with an N-methylated histidine side chain, it is particularly useful when the target sequence demands stereochemical inversion at the residue level and a side-chain modification that can alter intramolecular interactions within the growing peptide.

4. Stereodefined Reference Peptides

Boc-D-His(1-Me)-OH is also used to prepare stereochemically defined reference peptides for analytical and method-development purposes, including peptide characterization by LC-MS and comparative studies of isomeric or stereochemical variants. In these workflows, the D configuration and the N-methylated imidazole side chain provide a clear structural signature that helps distinguish the target residue environment from closely related histidine derivatives. Researchers use such reference materials to validate peptide assembly outcomes, confirm sequence integrity, and support interpretation of analytical data when comparing stereochemical variants and side-chain-substituted analogs.

1. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

2. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

3. Cationic cell-penetrating peptides are potent furin inhibitors

4. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

5. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis